Inventor
Jean-Paul Soulillou
Inventor
Nantes, FR
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07KPeptides29%
C12NMicroorganisms or enzymes6%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
PatentTitleYear
11,084,871Composition with reduced immunogenicity20219,447,182'Antibodies directed against the alpha chain of IL7 receptor—their use for the preparation of drug candidates'20168,932,808'Methods and compositions for determining a graft tolerant phenotype in a subject'20157,723,482'Anti-CD28 antibody'20106,214,342'Method for increasing mean survival times of transplants with LFA-1-specific antibodies'20015,672,486'Protein polyligands joined to a stable protein core'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2021Based in Nantes, FR· patent location history
2001Patents assigned to IMTIX SANGSTAT (1)· patent assignee history
2010–2021Patents assigned to INST NAT SANTE RECH MED (4)· patent assignee history
2015Patents assigned to BROUARD SOPHIE (1)· patent assignee history
2016Patents assigned to EFFIMUNE (1)· patent assignee history
2016Patents assigned to INST NAT DE LA SANTE ET LA RECH MEDICALE (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INST NAT SANTE RECH MED | 4 | 2010–2021 |
| BROUARD SOPHIE | 1 | 2015 |
| EFFIMUNE | 1 | 2016 |
| IMTIX SANGSTAT | 1 | 2001 |
| INST NAT DE LA SANTE ET LA RECH MEDICALE | 1 | 2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Nantes, FR | 6 | 1997–2021 |